Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal
- PMID: 16969832
- DOI: 10.1002/mus.20644
Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal
Abstract
We compared early- with late-onset cases in 86 patients with familial amyloidotic polyneuropathy type I (FAP). Among these patients, 43 presented before age 50 (early-onset) and 43 after this age (late-onset). Sex and geographical distribution were similar, although a family history of the disorder was more frequent in early-onset cases. In late-onset disease, autonomic dysfunction was less frequent, but organ involvement and severe neuropathic pain were more frequent. Neurophysiological measurements were similar. FAP is a cause of neuropathy in elderly patients, in particular in those presenting with neuropathic pain.
Similar articles
-
Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy.J Neurol Sci. 2009 Dec 15;287(1-2):178-84. doi: 10.1016/j.jns.2009.07.028. Epub 2009 Aug 25. J Neurol Sci. 2009. PMID: 19709674
-
Clinicopathologic and genetic features of early- and late-onset FAP type I (FAP ATTR Val30Met) in Japan.Amyloid. 2003 Aug;10 Suppl 1:32-8. Amyloid. 2003. PMID: 14640040
-
Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus.J Neurol Sci. 2008 Jul 15;270(1-2):133-40. doi: 10.1016/j.jns.2008.02.019. Epub 2008 Apr 14. J Neurol Sci. 2008. PMID: 18410945
-
Genetic epidemiology of familial amyloid polyneuropathy in the Balearic Islands (Spain).Amyloid. 2005 Mar;12(1):54-61. doi: 10.1080/13506120500032741. Amyloid. 2005. PMID: 16076612 Review.
-
Familial amyloid polyneuropathy and liver transplantation.J Hepatol. 2004 Aug;41(2):188-94. doi: 10.1016/j.jhep.2004.06.004. J Hepatol. 2004. PMID: 15288465 Review. No abstract available.
Cited by
-
Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathy.Front Neurol. 2023 Oct 5;14:1242815. doi: 10.3389/fneur.2023.1242815. eCollection 2023. Front Neurol. 2023. PMID: 37869146 Free PMC article. Review.
-
Familial amyloidotic polyneuropathy: current and emerging treatment options for transthyretin-mediated amyloidosis.Appl Clin Genet. 2012 Jun 18;5:37-41. doi: 10.2147/TACG.S19903. Print 2012. Appl Clin Genet. 2012. PMID: 23776379 Free PMC article.
-
Diagnostic challenges in systemic amyloidosis: a case report with clinical and laboratorial pitfalls.Autops Case Rep. 2021 Jan 10;11:e2021326. doi: 10.4322/acr.2021.326. eCollection 2021. Autops Case Rep. 2021. PMID: 34631606 Free PMC article.
-
Brazilian consensus for diagnosis, management and treatment of hereditary transthyretin amyloidosis with peripheral neuropathy: second edition.Arq Neuropsiquiatr. 2023 Mar;81(3):308-321. doi: 10.1055/s-0043-1764412. Epub 2023 Apr 14. Arq Neuropsiquiatr. 2023. PMID: 37059440 Free PMC article.
-
Chance or challenge, spoilt for choice? New recommendations on diagnostic and therapeutic considerations in hereditary transthyretin amyloidosis with polyneuropathy: the German/Austrian position and review of the literature.J Neurol. 2021 Oct;268(10):3610-3625. doi: 10.1007/s00415-020-09962-6. Epub 2020 Jun 4. J Neurol. 2021. PMID: 32500375 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous